Amgen Inc. (AMGN)
NASDAQ: AMGN · Real-Time Price · USD
410.95
+6.09 (1.51%)
At close: Aug 7, 2026, 4:00 PM EDT
410.89
-0.06 (-0.01%)
After-hours: Aug 7, 2026, 7:59 PM EDT

Amgen Revenue

Amgen had revenue of $10.05B in the quarter ending June 30, 2026, with 9.53% growth. This brings the company's revenue in the last twelve months to $38.10B, up 9.10% year-over-year. In the year 2025, Amgen had annual revenue of $36.75B with 9.95% growth.

Revenue (ttm)
$38.10B
Revenue Growth
+9.10%
P/S Ratio
5.83
Revenue / Employee
$1,209,365
Employees
31,500
Market Cap
222.17B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202536.75B3.33B9.95%
Dec 31, 202433.42B5.23B18.57%
Dec 31, 202328.19B1.87B7.09%
Dec 31, 202226.32B344.00M1.32%
Dec 31, 202125.98B555.00M2.18%
Dec 31, 202025.42B2.06B8.83%
Dec 31, 201923.36B-385.00M-1.62%
Dec 31, 201823.75B898.00M3.93%
Dec 31, 201722.85B-142.00M-0.62%
Dec 31, 201622.99B1.33B6.14%
Dec 31, 201521.66B1.60B7.97%
Dec 31, 201420.06B1.39B7.43%
Dec 31, 201318.68B1.41B8.17%
Dec 31, 201217.27B1.68B10.80%
Dec 31, 201115.58B529.00M3.51%
Dec 31, 201015.05B411.00M2.81%
Dec 31, 200914.64B-361.00M-2.41%
Dec 31, 200815.00B232.00M1.57%
Dec 31, 200714.77B503.00M3.53%
Dec 31, 200614.27B1.84B14.79%
Dec 31, 200512.43B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Johnson & Johnson97.93B
Merck & Co.66.57B
AbbVie64.39B
Pfizer63.70B
AstraZeneca61.37B
Novartis AG56.69B
Sanofi55.89B
Novo Nordisk50.34B
Revenue Rankings